Noel Filipe de Miranda
Noel Filipe de Miranda
Principal Investigator at Leiden University Medical Center
Verified email at
Cited by
Cited by
Neoantigen landscape dynamics during human melanoma–T cell interactions
EME Verdegaal, NFCC De Miranda, M Visser, T Harryvan, ...
Nature 536 (7614), 91-95, 2016
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
T Duhen, R Duhen, R Montler, J Moses, T Moudgil, NF de Miranda, ...
Nature communications 9 (1), 1-13, 2018
The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers
LL Kodach, E Wiercinska, NFCC de Miranda, SA Bleuming, AR Musler, ...
Gastroenterology 134 (5), 1332-1341. e3, 2008
Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I–II colon cancer patients
WE Mesker, GJ Liefers, JMC Junggeburt, GW van Pelt, P Alberici, ...
Analytical Cellular Pathology 31 (3), 169-178, 2009
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas
K Georgiou, L Chen, M Berglund, W Ren, NFCC de Miranda, S Lisboa, ...
Blood 127 (24), 3026-3034, 2016
Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatment
YM Schrage, IH Briaire-de Bruijn, NFCC de Miranda, J van Oosterwijk, ...
Cancer research 69 (15), 6216-6222, 2009
HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression
JWF Dierssen, NFCC de Miranda, S Ferrone, M van Puijenbroek, ...
BMC cancer 7 (1), 33, 2007
Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients
NFCC de Miranda, K Georgiou, L Chen, C Wu, Z Gao, A Zaravinos, ...
Blood 124 (16), 2544-2553, 2014
Genetic heterogeneity in primary and relapsed mantle cell lymphomas: impact of recurrent CARD11 mutations
C Wu, NFCC de Miranda, L Chen, AM Wasik, L Mansouri, W Jurczak, ...
Oncotarget 7 (25), 38180, 2016
DNA repair genes are selectively mutated in diffuse large B cell lymphomas
NFCC de Miranda, R Peng, K Georgiou, C Wu, EF Sörqvist, M Berglund, ...
Journal of Experimental Medicine 210 (9), 1729-1742, 2013
Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis
EH Lips, R Van Eijk, EJR De Graaf, J Oosting, NFCC De Miranda, ...
BMC cancer 8 (1), 314, 2008
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
F Finotello, C Mayer, C Plattner, G Laschober, D Rieder, H Hackl, ...
Genome medicine 11 (1), 1-20, 2019
High‐resolution multi‐parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin‐embedded tissues
WE Corver, NT ter Haar, EJ Dreef, NFCC Miranda, FA Prins, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005
DNA repair: the link between primary immunodeficiency and cancer
NFCC de Miranda, A Björkman, Q Pan‐Hammarström
Annals of the New York Academy of Sciences 1246 (1), 50-63, 2011
Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas
M Nielsen, NFCC De Miranda, M Van Puijenbroek, ES Jordanova, ...
BMC cancer 9 (1), 184, 2009
Low penetrance of a SDHB mutation in a large Dutch paraganglioma family
FJ Hes, MM Weiss, SA Woortman, NF De Miranda, PA Van Bunderen, ...
BMC medical genetics 11 (1), 92, 2010
Memory CD4+ T cells are generated in the human fetal intestine
N Li, V van Unen, T Abdelaal, N Guo, SA Kasatskaya, K Ladell, ...
Nature immunology 20 (3), 301-312, 2019
Progression and tumor heterogeneity analysis in early rectal cancer
EH Lips, R van Eijk, EJR de Graaf, PG Doornebosch, NFCC de Miranda, ...
Clinical Cancer Research 14 (3), 772-781, 2008
Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtype
M Kostine, AHG Cleven, NFCC de Miranda, A Italiano, AM Cleton-Jansen, ...
Modern Pathology 29 (9), 1028-1037, 2016
Integral analysis of p53 and its value as prognostic factor in sporadic colon cancer
AF Sarasqueta, G Forte, WE Corver, NF de Miranda, D Ruano, R van Eijk, ...
BMC cancer 13 (1), 277, 2013
The system can't perform the operation now. Try again later.
Articles 1–20